RAP media thread., page-2940

An illuminating interview with Alodokter's co-founder and an Operations Head doctor.


Cough Test, Health Technology Innovation in Alodokter Application (akurat.co)


You will need to click the "Translate page from Indonesian button" which pops up as the original article is in Bahasa Indonesian.

The last paragraph is prophetic as it alludes to the ResApp technology being used for the COVID-19 test which is why Pfizer is particularly interested in the company and is a massive validation of the technology.

Despite the "rockstar" nature of the COVID-19 screening test, don't forget the "bread and butter" aspect of the ResAppDX diagnostic tests which in places like Indonesia (270 million people or 10 times Australia's population) will grow rapidly in its use and acceptance. COVID-19 is the headline news now and the foreseeable future, but ResAppDX will still be the backbone anchoring the company for patient diagnosis, monitoring and management.

Also much has already been said, discussed and debated as to why the BOD approved the the Pfizer takeover. My thoughts are that it served 4 purposes:-

1. Commit one entity to put some $$$ on the table
2. Bring the eyes of the world, and especially other interested parties who have been sitting on the fence with the free publicity it generates.
3. Draw in alternative suitors and partners
4. Solve the short term CR funding issue by getting Pfizer's $3M ($4M with enrolment milestone) which in most likelihood was tied to the BOD approval of the takeover bid.

Lastly, the fate of the company is in the shareholders hands to approve the takeover, not the BOD. Maybe, they did have some brains after all, contrary to some opinions.